Computational models of VEGF-associated angiogenic processes in cancer

Mathematical Medicine and Biology

Volumn 29, Issue 1, 2012, Pages 85-94

  Stefanini, Marianne O ^a   Qutub, Amina A ^b   Mac Gabhann, Feilim ^a   Popel, Aleksander S ^a  

^a Johns Hopkins University   (United States)

^b Rice University   (United States)

Author keywords

Angiogenesis; Computational biology; Systems biology

Indexed keywords

BLOOD VESSELS; CELL ENGINEERING; CELL SIGNALING; COMPUTATIONAL METHODS; DISEASES; ENDOTHELIAL CELLS; TUMORS;

ANGIOGENESIS; ANGIOGENIC PROCESS; CANCER CELLS; COMPUTATIONAL BIOLOGY; COMPUTATIONAL MODELLING; DIFFUSION LIMITATIONS; GROWING MASS; OXYGEN DIFFUSION; SYSTEMS BIOLOGY; TUMOR ANGIOGENESIS;

COMPUTATION THEORY;

EID: 84858172352     PISSN: 14778599     EISSN: 14778602     Source Type: Journal    
DOI: 10.1093/imammb/dqq025     Document Type: Article

References (44)

1. ANDERSON, A. R. & QUARANTA, V. (2008) Integrative mathematical oncology. Nat. Rev. Cancer, 8, 227-234.
2. BEARER, E. L., LOWENGRUB, J. S., FRIEBOES, H. B., CHUANG, Y. L., JIN, F., WISE, S. M., FERRARI, M., AGUS, D. B. & CRISTINI, V. (2009) Multiparameter computational modeling of tumor invasion. Cancer Res., 69, 4493-4501.
3. BENTLEY, K., GERHARDT, H. & BATES, P. A. (2008) Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. J. Theor. Biol., 250, 25-36.
4. BENTLEY, K., MARIGGI, G., GERHARDT, H. & BATES, P. A. (2009) Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis. PLoS Comput. Biol., 5, e1000549.
5. BILLY, F., RIBBA, B., SAUT, O., MORRE-TROUILHET, H., COLIN, T., BRESCH, D., BOISSEL, J. P., GRENIER, E. & FLANDROIS, J. P. (2009) A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy. J. Theor. Biol., 260, 545-562.
6. BONABEAU, E. (2002) Agent-based modeling: methods and techniques for simulating human systems. Proc. Natl. Acad. Sci. USA, 99, Suppl 3, 7280-7287.
7. BYRNE, H. M. (2010) Dissecting cancer through mathematics: from the cell to the animal model. Nat. Rev. Cancer, 10, 221-230.
8. CHAPLAIN, M. A., MCDOUGALL, S. R. & ANDERSON, A. R. (2006) Mathematical modeling of tumor-induced angiogenesis. Annu. Rev. Biomed. Eng., 8, 233-257.
9. DAYAN, F., MONTICELLI, M., POUYSSEGUR, J. & PECOU, E. (2009) Gene regulation in response to graded hypoxia: the non-redundant roles of the oxygen sensors PHD and FIH in the HIF pathway. J. Theor. Biol., 259, 304-316.
10. DEWHIRST, M. W., CAO, Y., LI, C. Y. & MOELLER, B. (2007) Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother. Oncol., 83, 249-255.
11. FERRARA, N. (2005) The role of VEGF in the regulation of physiological and pathological angiogenesis. Exs., 209-231. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15617481.
12. FOLKMAN, J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82, 4-6.
13. GAO, P., ZHANG, H., DINAVAHI, R., LI, F., XIANG, Y., RAMAN, V., BHUJWALLA, Z. M., FELSHER, D. W., CHENG, L., PEVSNER, J., LEE, L. A., SEMENZA, G. L. & DANG, C. V. (2007) HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell, 12, 230-238.
14. GAUR, P., BOSE, D., SAMUEL, S. & ELLIS, L. M. (2009) Targeting tumor angiogenesis. Semin. Oncol., 36, S12-S19.
15. JI, J. W., MAC GABHANN, F. & POPEL, A. S. (2007) Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am. J. Physiol. Heart Circ. Physiol., 293, H3740-H37409.
16. JI, J. W., TSOUKIAS, N. M., GOLDMAN, D. & POPEL, A. S. (2006) A computational model of oxygen transport in skeletal muscle for sprouting and splitting modes of angiogenesis. J. Theor. Biol., 241, 94-108.
17. KARAGIANNIS, E. D. & POPEL, A. S. (2006) Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model. J. Theor. Biol., 238, 124-145.
18. KOHN, K. W., RISS, J., APRELIKOVA, O., WEINSTEIN, J. N., POMMIER, Y. & BARRETT, J. C. (2004) Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system. Mol. Biol. Cell, 15, 3042-3052.
19. KUT, C., MAC GABHANN, F. & POPEL, A. S. (2007) Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br. J. Cancer, 97, 978-985.
20. LEVINE, H. A., PAMUK, S., SLEEMAN, B. D. & NILSEN-HAMILTON, M. (2002) Mathematical modelling of tumour angiogenesis and the action of angiostating as a protease inhibitor. J. Theor. Med., 4, 133-145.
21. MAC GABHANN, F., JI, J. W. & POPEL, A. S. (2007) VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle. J. Appl. Physiol., 102, 722-734.
22. MAC GABHANN, F. & POPEL, A. S. (2006) Targeting neuropilin-1 to inhibit VEGF signaling in cancer: comparison of therapeutic approaches. PLoS Comput. Biol., 2, e180.
23. MAC GABHANN, F. & POPEL, A. S. (2007) Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys. Chem., 128, 125-139.
24. MAC GABHANN, F. & POPEL, A. S. (2008) Systems biology of vascular endothelial growth factors. Microcirculation, 15, 715-738.
25. MANTZARIS, N. V., WEBB, S. & OTHMER, H. G. (2004) Mathematical modeling of tumor-induced angiogenesis. J. Math. Biol., 49, 111-187.
26. MCDOUGALL, S. R., ANDERSON, A. R. & CHAPLAIN, M. A. (2006) Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J. Theor. Biol., 241, 564-589.
27. MILDE, F., BERGDORF, M. & KOUMOUTSAKOS, P. (2008) A hybrid model for three-dimensional simulations of sprouting angiogenesis. Biophys. J., 95, 3146-3160.
28. MOELLER, B. J., CAO, Y., LI, C. Y. & DEWHIRST, M. W. (2004) Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell, 5, 429-441.
29. OWEN, M. R., ALARCON, T., MAINI, P. K. & BYRNE, H. M. (2009) Angiogenesis and vascular remodelling in normal and cancerous tissues. J. Math. Biol., 58, 689-721.
30. PEIRCE, S. M. (2008) Computational and mathematical modeling of angiogenesis. Microcirculation, 15, 739-751.
31. QUTUB, A. A., MAC GABHANN, F., KARAGIANNIS, E. D., VEMPATI, P. & POPEL, A. S. (2009) Multiscale models of angiogenesis. IEEE Eng. Med. Biol. Mag., 28, 14-31.
32. QUTUB, A. A. & POPEL, A. S. (2006) A computational model of intracellular oxygen sensing by hypoxiainducible factor HIF1 alpha. J. Cell Sci., 119, 3467-3480.
33. QUTUB, A. A. & POPEL, A. S. (2007) Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia. Biochim. Biophys. Acta, 1773, 1511-1525.
34. QUTUB, A. A. & POPEL, A. S. (2008) Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol. Cell Biol., 28, 5106-5119.
35. QUTUB, A. A. & POPEL, A. S. (2009) Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting. BMC Syst. Biol., 3, 13.
36. SEFCIK, L. S., WILSON, J. L., PAPIN, J. A. & BOTCHWEY, E. A. (2010) Harnessing systems biology approaches to engineer functional microvascular networks. Tissue Eng. Part B Rev., 16, 361-370.
37. SEMENZA, G. L. (2000) HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev., 19, 59-65.
38. STEFANINI, M. O., WU, F. T., MAC GABHANN, F. & POPEL, A. S. (2008) A compartment model of VEGF distribution in blood, healthy and diseased tissues. BMC Syst. Biol., 2, 77.
39. STEFANINI, M. O., WU, F. T., MAC GABHANN, F. & POPEL, A. S. (2009) The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput. Biol., 5, e1000622.
40. STEFANINI, M. O., WU, F. T., MAC GABHANN, F. & POPEL, A. S. (2010) Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model. Cancer Res., 70, 1-9.
41. WU, F. T., STEFANINI, M. O., MAC GABHANN, F. & POPEL, A. S. (2009) A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap. PLoS One, 4, e5108.
42. YU, Y., WANG, G., SIMHA, R., PENG, W., TURANO, F. & ZENG, C. (2007) Pathway switching explains the sharp response characteristic of hypoxia response network. PLoS Comput. Biol., 3, e171.
43. YUCEL, M. A. & KURNAZ, I. A. (2007) An in silico model for HIF-alpha regulation and hypoxia response in tumor cells. Biotechnol. Bioeng., 97, 588-600.
44. ZHOU, J., SCHMID, T., SCHNITZER, S. & BRUNE, B. (2006) Tumor hypoxia and cancer progression. Cancer Lett., 237, 10-21.